These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6219628)

  • 21. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
    Jakobsen P; Larsen FG; Larsen CG
    J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
    [No Abstract]   [Full Text] [Related]  

  • 22. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B; Reiners J; Spielmann H; Nau H
    Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
    De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
    J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment.
    Meyer E; de Bersaques J; Lambert WE; de Leenheer AP; Kint AH
    Acta Derm Venereol; 1993 Apr; 73(2):113-5. PubMed ID: 8103254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
    Geiger JM; Czarnetzki BM
    Dermatologica; 1988; 176(4):182-90. PubMed ID: 2967779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side-effect profile of acitretin therapy in psoriasis.
    Gupta AK; Goldfarb MT; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1989 Jun; 20(6):1088-93. PubMed ID: 2526824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J; Geiger JM
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etretinate: effect of milk intake on absorption.
    DiGiovanna JJ; Gross EG; McClean SW; Ruddel ME; Gantt G; Peck GL
    J Invest Dermatol; 1984 Jun; 82(6):636-40. PubMed ID: 6233379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
    Saurat JH; Geiger JM; Amblard P; Beani JC; Boulanger A; Claudy A; Frenk E; Guilhou JJ; Grosshans E; Mérot Y
    Dermatologica; 1988; 177(4):218-24. PubMed ID: 2976000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
    Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
    J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
    [No Abstract]   [Full Text] [Related]  

  • 33. Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
    Bouvy ML; Sturkenboom MC; Cornel MC; De Jong-Van den Berg LT; Stricker BH; Wesseling H
    Pharm Weekbl Sci; 1992 Apr; 14(2):33-7. PubMed ID: 1388261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, delivered to cultured human fibroblasts by serum proteins. Lack of evidence for perturbation of LDL catabolism.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):102-6. PubMed ID: 2146974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
    Halioua B; Saurat JH
    Br J Dermatol; 1990 Jun; 122 Suppl 36():135-50. PubMed ID: 2142437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cis-trans interconversion of acitretin in man.
    Geiger JM; Brindley CJ
    Skin Pharmacol; 1988; 1(4):230-6. PubMed ID: 2978787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
    Ashley JM; Lowe NJ; Borok ME; Alfin-Slater RB
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):76-82. PubMed ID: 2969924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis.
    Olsen EA; Weed WW; Meyer CJ; Cobo LM
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):681-6. PubMed ID: 2530251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acitretin improves psoriasis in a dose-dependent fashion.
    Goldfarb MT; Ellis CN; Gupta AK; Tincoff T; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):655-62. PubMed ID: 2967310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.